Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2022

View Archived Issues

PPAR-delta/beta modulates colon tumorigenesis

Prokineticin-2 levels are dramatically decreased in sepsis and septic shock

New G2019S mutant leucine-rich repeat kinase 2 inhibitors discovered at Merck & Co.

Innovstone Therapeutics presents new protein arginine N-methyltransferase 5 inhibitors

Apoptosis regulator BAX inhibitors patented by Albert Einstein College of Medicine

Wuhan LL Science and Technology Development presents new MAPK8 inhibitors

New antifungals synthesized at Kyung Hee University

Pimavanserin exerts anticancer effects via autophagy-mediated apoptosis

AMG-650: a first-in-class KIF18A inhibitor for the treatment of chromosomally unstable cancers

Ube Industries and HiLung to codevelop LPA1 antagonist HL-001 for IPF

Cybin completes in vivo studies for deuterated psilocybin analogue CYB-003 for MDD

Novel ferroptosis inhibitor mitigates cerebral ischemic injury in rat

Alpha Cognition reports in vivo and in vitro data on ALPHA-0602 for ALS

Protein is marker, target for diabetic neuropathy

Researchers present new Slc39a14-knockout dystonia murine model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...